Germany Dupuytren’s Disease Market Size & Outlook

The dupuytren’s disease market in Germany is expected to reach a projected revenue of US$ 484.5 million by 2030. A compound annual growth rate of 1.7% is expected of Germany dupuytren’s disease market from 2023 to 2030.
Revenue, 2022 (US$M)
$424.9
Forecast, 2030 (US$M)
$484.5
CAGR, 2023 - 2030
1.7%
Report Coverage
Germany

Germany dupuytren’s disease market highlights

  • The Germany dupuytren’s disease market generated a revenue of USD 424.9 million in 2022 and is expected to reach USD 484.5 million by 2030.
  • The Germany market is expected to grow at a CAGR of 1.7% from 2023 to 2030.
  • In terms of segment, type ii was the largest revenue generating disease type in 2022.
  • Type II is the most lucrative disease type segment registering the fastest growth during the forecast period.


Dupuytren’s disease market data book summary

Market revenue in 2022USD 424.9 million
Market revenue in 2030USD 484.5 million
Growth rate1.7% (CAGR from 2022 to 2030)
Largest segmentType ii
Fastest growing segmentType II
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationType I, Type II, Type III
Key market players worldwideBayer AG, Novartis AG ADR, Pfizer Inc, Bristol-Myers Squibb Co, GSK PLC, AstraZeneca PLC, Hikma Pharmaceuticals PLC, LEO Pharma, Fresenius SE & Co KGaA, Nantong Jinghua Pharmaceutical, Actiza Pharmaceutical Pvt. Ltd, Eppendorf, Endo Pharmaceuticals, Spear Pharmaceuticals


Other key industry trends

  • In terms of revenue, Germany accounted for 10.3% of the global dupuytren’s disease market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, UK dupuytren’s disease market is projected to lead the regional market in terms of revenue in 2030.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 485.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Dupuytren’s Disease Market Scope

Dupuytren’s disease market segmentation & scope

Dupuytren’s Disease Market Companies

Name Profile # Employees HQ Website

Germany dupuytren’s disease market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dupuytren’s disease market will help companies and investors design strategic landscapes.


Type ii was the largest segment with a revenue share of 62.51% in 2022. Horizon Databook has segmented the Germany dupuytren’s disease market based on type i, type ii, type iii covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Germany dupuytren’s disease market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Germany dupuytren’s disease market databook

  • Our clientele includes a mix of dupuytren’s disease market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Germany dupuytren’s disease market, including forecasts for subscribers. This country databook contains high-level insights into Germany dupuytren’s disease market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Germany dupuytrens disease market report size, by disease type, 2018-2030 (US$M)

Germany Dupuytren’s Disease Market Share, 2022 & 2030 (US$M)

Germany dupuytrens disease market report size, by disease type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more